Study finds secukinumab effective for moderate to severe scalp psoriasisAugust 9, 2017PsoriasisPsoriatic Arthritis
First interchangeability study for an adalimumab biosimilar has begunJuly 31, 2017PsoriasisPsoriatic Arthritis
First IL-23 blocker, guselkumab, earns FDA approval for psoriasisJuly 13, 2017PsoriasisPsoriatic Arthritis
Early phase III data positive for adalimumab biosimilar, for both psoriasis and PsAJuly 1, 2017Psoriatic ArthritisPsoriasis
Ustekinumab trumps TNF-blockade for enthesitis in patients with psoriatic arthritisJune 17, 2017Psoriatic Arthritis
_web.jpg)
